Raymond James Financial Inc Compugen LTD Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Compugen LTD stock. As of the latest transaction made, Raymond James Financial Inc holds 67,041 shares of CGEN stock, worth $172,295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,041Holding current value
$172,295% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGEN
# of Institutions
77Shares Held
12MCall Options Held
79.2KPut Options Held
12.7K-
Silverarc Capital Management, LLC1.5MShares$3.86 Million0.68% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.29MShares$3.31 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.09MShares$2.81 Million0.85% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$2.62 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD990KShares$2.54 Million0.06% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $223M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...